Serum Endocan and Circadian Heart Rate Variability in Non-Dialysis Stage 5 Chronic Kidney Disease Patients.

Yu Bao,Yi-An Wang,Hua Xiao,Ying Wang,Yan Wu,Yue Yan,Zhu,Mei Ni,Cheng-Xian Pi,Ming-Yue Liu,Jun-Hua Yang,Yan-Ting Li,Xin-Kui Tian,Tao Wang,Xing-Wei Zhe
DOI: https://doi.org/10.1007/s11255-018-1993-8
IF: 2.2662
2018-01-01
International Urology and Nephrology
Abstract:Chronic kidney disease (CKD) is very common now and is associated with high overall and cardiovascular mortality. Numerous studies have reported that elevated heart rate (HR) is a risk factor for cardiovascular mortality. We investigated the link between serum endocan and circadian heart rate variability in non-dialysis stage 5 CKD patients.
What problem does this paper attempt to address?